(Total Views: 644)
Posted On: 05/27/2022 5:45:24 AM
Post# of 154147
MGK wrote:
If a poster on YMB is the only suggestion we have that LL continued to be administered, I wouldn't assume that CYDY will discuss at the ASCO conference any results beyond what was covered in the Preliminary Results and in the "Results" I quoted in the CYDY description of their ASCO presentation.
It's assumptions like that, MGK, that erode the confidence a reader has in your posts. You seem to proceed from your hopes directly to belief; you seem to make leaps of faith. This says great things about you as a person, but not as a poster.
God, I hope I'm wrong and you are right. If they could add to that 12+ months of median Overall Survival by even a couple of months, it would make Leron a candidate (again) for Breakthrough Designation for mTNBC.
Quote:
believe they will elaborate and discuss what happened following the close of the trial in november, in the presentation on June 6-7. drD on YMB has said LL continued to be administered as per schedule.
If a poster on YMB is the only suggestion we have that LL continued to be administered, I wouldn't assume that CYDY will discuss at the ASCO conference any results beyond what was covered in the Preliminary Results and in the "Results" I quoted in the CYDY description of their ASCO presentation.
It's assumptions like that, MGK, that erode the confidence a reader has in your posts. You seem to proceed from your hopes directly to belief; you seem to make leaps of faith. This says great things about you as a person, but not as a poster.
God, I hope I'm wrong and you are right. If they could add to that 12+ months of median Overall Survival by even a couple of months, it would make Leron a candidate (again) for Breakthrough Designation for mTNBC.
(11)
(0)
